RECURRENT MALIGNANT GLIOMA
Clinical trials for RECURRENT MALIGNANT GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MALIGNANT GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT MALIGNANT GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with tough brain tumors: targeted radiation drug enters trial
Disease control Recruiting nowThis study tests a drug called Lutathera in children and young adults (ages 4 to 39) whose brain tumors have come back or are growing despite treatment. The drug delivers radiation directly to tumor cells that show up on a special PET scan. The goal is to find the safest dose and…
Matched conditions: RECURRENT MALIGNANT GLIOMA
Phase: PHASE1, PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated May 26, 2026 03:33 UTC
-
Cold virus engineered to attack brain tumors shows promise in early trial
Disease control Recruiting nowThis early-phase trial tests a new approach for people with recurrent high-grade glioma, a fast-growing brain cancer. Researchers use stem cells to carry a modified cold virus directly to the tumor via an artery, where the virus is designed to infect and kill cancer cells. The ma…
Matched conditions: RECURRENT MALIGNANT GLIOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Engineered immune cells take on recurrent brain tumors in first human trial
Disease control Recruiting nowThis early-phase study tests a new treatment called anti-GARP CAR T-cell therapy for people with recurrent high-grade glioma, a type of aggressive brain cancer. The therapy involves taking a patient's own immune cells, modifying them in a lab to recognize and attack cancer cells,…
Matched conditions: RECURRENT MALIGNANT GLIOMA
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:54 UTC